Position in BDSX
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,059,601
+$488,214 QoQ
Shares Held
46,989
+19.2% QoQ
Ownership
0.445%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#17
of 44 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BDSX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026GSA CAPITAL PARTNERS LLP holds $16,598,580 across 18 Diagnostics & Research names. BDSX ranks #4 (6.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NTRA |
Natera, Inc.
|
11,336 | $3,077,157 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
4,702 | $2,357,394 | |
| 3 | GH |
Guardant Health, Inc.
|
11,811 | $1,772,004 | |
| 4 | BDSX |
Biodesix Inc
This page
|
46,989 | $1,059,601 | |
| 5 | DGX |
Quest Diagnostics Inc
|
4,971 | $1,053,603 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
1,981 | $1,042,877 | |
| 7 | XGN |
Exagen Inc.
|
214,721 | $998,452 | |
| 8 | MTD |
Mettler Toledo International Inc/
|
619 | $790,778 |
All Filings in BDSX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,059,601 | 46,989 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $571,387 | 39,406 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $438,484 | 64,483 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $364,982 | 48,342 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $262,653 | 931,394 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $20,834 | 33,335 | Shares | Sole | 2025-05-08 | |
| No filing history on record for this holder in this stock. | ||||||